Neuralink says the FDA designated its Blindsight implant as a 'breakthrough device'
Sep 20, 2024•6 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
This could accelerate development of the tech, which aims to help restore blind patients' vision.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
For the best experience, listen in Metacast app for iOS or Android